期刊文献+

温热与羟基喜树碱(OPT)联合对胃腺癌(SGC-7901)细胞的作用 被引量:3

Effect of Combined Use of Hyperthermia and HYD Oxy-camptothecia(OPT)on Human Stomach Low Differentiation Cancer Cell Line SGC-7901 in vitro
下载PDF
导出
摘要 以体外长期培养胃低分化腺癌细胞系(SGC-7901)细胞为模型,采用水浴加温法对细胞的生长抑制规律进行了观察。表明:1)温热、OPT对SGC-7901细胞均有一定的抑制增殖和直接杀伤作用;温热与药物联合应用具有协同抑制增殖和杀伤细胞的作用。2)温热和OPT联合对SGC7901细胞的杀伤和生长抑制作用均较温热或药物单独作用强,但序贯方面以热药同时为佳。3)温热、OPT都可使SGC-7901细胞结构发生变化,单用以细胞变性为主,联合组多为不可逆性损伤。4)温热40℃作用后细胞爆发性生长,表明单纯加热低于42℃是不适宜的。 The low differentiation stomach gland cancer cell line(SGC-7901) which was established by Shanghai Sixth People's Hospital was used in this study.The inhibition pattern of cell growth was observed under water-heating with or without OPT(Camptothecia derivative).The results showed that:1.Both hyperthermia and OPT can inhibit the proliferation of the SGC-7901 cells and kill the cells directly.The inhibition effect can be enhanced by adding hyperthermia. 2.Hyperthermia in combination with OPT can check proliferation or kill more cells than singly hyperthermia or chemical agent. But the best killing effects of the sequences can be achieved when heating and the chemical drug used simultaneously.3.Both hyperthermia and OPT can change the cell structure.The principal change observed was cell degeneration when these factors were given alone, however, it was unreversible damage when combined.4. When heated at 40℃ for an hour, the cells growth kindled tremendously indicating that temperature lower than 42℃ is unfavorable in tissue of therapy.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1996年第2期134-137,共4页 Chinese Journal of Clinical Oncology
关键词 胃肿瘤 腺癌 热化疗 羟基喜树碱 药物疗法 Thermochemotherapy OPT Hypertherthermia Stomach gland cancer cell line
  • 相关文献

参考文献4

  • 1赵彼得,高频透热治癌,1993年
  • 2李振,恶性肿瘤的化学治疗与免疫治疗,1990年
  • 3周宁新,国外医学肿瘤学分册,1986年,1卷,30页
  • 4Lin Chaohong,Chin Med J,1984年,97卷,831页

同被引文献26

  • 1李格来,刘滋润,张光明,叶丹玲,毋传江,张铭芳,王热闹.大剂量顺铂腹腔灌注治疗恶性腹水的临床探讨[J].河南肿瘤学杂志,1994,7(4):305-306. 被引量:3
  • 2耿宝琴.紫杉醇类与喜树碱类的研究进展[J].实用肿瘤杂志,1995,10(4):199-201. 被引量:19
  • 3董锡裕,徐莉.喜树碱类抗癌药──又一世界性热门课题[J].中草药,1996,27(4):243-245. 被引量:15
  • 4Hsiang YH, Hertzberg R, Hecht S, et al. Camptothecin induces protein - linked DNA breaks via mammalian DNA topoisomerase Ⅰ [J]. J Biol Chem, 1985, 260 (27): 14873-14878.
  • 5Slichenmyer WJ, Rowinsky EK. Donehower RC, et al. The current status of camptothecin analogues as antitumor agents [J]. JNatl Cancer Inst, 1993, 85 (4): 271-291.
  • 6Crow RT, Crothers DM. Structural modifications of camptothecin and effects on topoisomerase I inhibition [J]. J Med Chem, 1992, 35 (22): 4160-4164.
  • 7哈献文.喜树碱疗效不高的原因[J].中国肿瘤,1995,4(12):31-31.
  • 8Bertrand R, O' ConnorPM, KerriganD, et al. Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT - 29 cells [ J ].Eur J Cancer, 1992, 28A (4-5): 743-748.
  • 9Sugimoto Y, Tsukahara S, OH Hara T, et al. Elevated expression of DNA topoisomerase Ⅱ in camprothecin - resistant human tumor cell lines [J]. Cancer Res, 1990, 50 (24):7962 - 7965.
  • 10Anzai H, Frost P, Abbruzzese JL. Synergistic cytotoxicity with 2' - deoxy, 5 - azacytidine and topotecan in vitro and in vivo [J]. Cancer Res, 1992, 52 (8): 2180-2185.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部